Atypical antipsychotics as add-on treatment in late-life depression
CLINICAL INTERVENTIONS IN AGING, vol.11, pp.1193-1198, 2016 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 11
- Publication Date: 2016
- Doi Number: 10.2147/cia.s114244
- Journal Name: CLINICAL INTERVENTIONS IN AGING
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.1193-1198
- Istanbul University Affiliated: No
Abstract
Background: Second-generation antipsychotics (SGAs) have been used in the augmentation of treatment-resistant depression. However, little is known about their effectiveness, tolerability, and adverse events in the treatment of late-life depression, which were the aim of this study.